Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Mol Cancer Res. 2019 May 1;17(8):1613–1626. doi: 10.1158/1541-7786.MCR-18-1235

Table 2.

Summary of immunohistochemical findings in patients with TFE3-RCC.

Negative Positive 1+ 2+
TFE3 0%(0/9) 100%(9/9) 1 8
GPNMB 0%(0/9) 100%(9/9) 2 7
Cathepsin K 33%(3/9) 67%(6/9) 4 2